EUVIMEDEUVIMED entdecken
Open Access

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance

Kathleen Conway iD, Sharon N Edmiston iD, Amanda Vondras iD, Allison Reiner, David L Corcoran iD, Ronglai Shen iD, Eloise A Parrish iD, Honglin Hao, Lan Lin, Jessica M Kenney, Gbemisola Ilelaboye iD, Caroline E Kostrzewa iD und 39 weitere

JCO Precision Oncology · 2024-11 · (8)

DOI: 10.1200/po-24-00375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Precision Oncology, 2024-11. Verfasst von Kathleen Conway und 50 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of North Carolina, Chapel Hill, NC. Hauptthemen laut MEDLINE: Melanoma, DNA Methylation, Skin Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Patients with stage II and III cutaneous primary melanoma vary considerably in their risk of melanoma-related death. We explore the ability of methylation profiling to distinguish primary melanoma methylation classes and their associations with clinicopathologic characteristics and survival. MATERIALS AND METHODS InterMEL is a retrospective case-control study that assembled primary cutaneous melanomas from American Joint Committee on Cancer (AJCC) 8th edition stage II and III patients diagnosed between 1998 and 2015 in the United States and Australia. Cases are patients who died of melanoma within 5 years from original diagnosis. Controls survived longer than 5 years without evidence of melanoma recurrence or relapse. Methylation classes, distinguished by consensus clustering of 850K methylation data, were evaluated for their clinicopathologic characteristics, 5-year survival status, and differentially methylated gene sets. RESULTS Among 422 InterMEL melanomas, consensus clustering revealed three primary melanoma methylation classes (MethylClasses): a CpG island methylator phenotype (CIMP) class, an intermediate methylation (IM) class, and a low methylation (LM) class. CIMP and IM were associated with higher AJCC stage (both P = .002), Breslow thickness (CIMP P = .002; IM P = .006), and mitotic index (both P < .001) compared with LM, while IM had higher N stage than CIMP ( P = .01) and LM ( P = .007). CIMP and IM had a 2-fold higher likelihood of 5-year death from melanoma than LM (CIMP odds ratio [OR], 2.16 [95% CI, 1.18 to 3.96]; IM OR, 2.00 [95% CI, 1.12 to 3.58]) in a multivariable model adjusted for age, sex, log Breslow thickness, ulceration, mitotic index, and N stage. Despite more extensive CpG island hypermethylation in CIMP, CIMP and IM shared similar patterns of differential methylation and gene set enrichment compared with LM. CONCLUSION Melanoma MethylClasses may provide clinical value in predicting 5-year death from melanoma among patients with primary melanoma independent of other clinicopathologic factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaDNA MethylationSkin NeoplasmsNeoplasm StagingHumansMaleFemaleMiddle AgedRetrospective StudiesAgedPrognosisCase-Control StudiesAdultAged, 80 and over

Autor:innen und Institutionen

  • Department of Epidemiology, University of North Carolina, Chapel Hill, NC.
  • Department of Dermatology, University of North Carolina, Chapel Hill, NC.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Department of Applied Mathematics and Statistics, State University of New York, Stony Brook, NY.

ORCID-Profile: Kathleen Conway, Sharon N Edmiston, Amanda Vondras, David L Corcoran, Ronglai Shen, Eloise A Parrish, Gbemisola Ilelaboye, Caroline E Kostrzewa, Pei Fen Kuan, Tim K Lee, Eva Hernando, Paul B Googe, Christopher I Amos, Marc S Ernstoff, Anne E Cust, James S Wilmott, Richard A Scolyer, Graham J Mann, Jennifer Ko, Judy R Rees, Shaofeng Yan, Eduardo Nagore, Marcus Bosenberg, Bonnie Gould Rothberg, Iman Osman, Jeffrey E Lee, Sheri L Holmen, Pauline Funchain, Elise Brunsgaard, Tawny Boyce, Irene Orlow, Marianne Berwick, Nancy E Thomas

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • NIEHS NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Conway, K., Edmiston, S. N., Vondras, A., Reiner, A., Corcoran, D. L., Shen, R., Parrish, E. A., Hao, H., Lin, L., Kenney, J. M., Ilelaboye, G., Kostrzewa, C. E., Kuan, P. F., Busam, K. J., Lezcano, C., Lee, T. K., Hernando, E., Googe, P. B., Ollila, D. W., …, & InterMEL Study Group (2024). DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precision Oncology. https://doi.org/10.1200/po-24-00375

Vancouver

Conway K, Edmiston SN, Vondras A, Reiner A, Corcoran DL, Shen R, et al. DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance. JCO Precision Oncology. 2024. doi:10.1200/po-24-00375

BibTeX
@article{Conway2024,
  author = {Conway, Kathleen and Edmiston, Sharon N and Vondras, Amanda and Reiner, Allison and Corcoran, David L and Shen, Ronglai and Parrish, Eloise A and Hao, Honglin and Lin, Lan and Kenney, Jessica M and Ilelaboye, Gbemisola and Kostrzewa, Caroline E and Kuan, Pei Fen and Busam, Klaus J and Lezcano, Cecilia and Lee, Tim K and Hernando, Eva and Googe, Paul B and Ollila, David W and Moschos, Stergios and Gorlov, Ivan and Amos, Christopher I and Ernstoff, Marc S and Cust, Anne E and Wilmott, James S and Scolyer, Richard A and Mann, Graham J and Vergara, Ismael A and Ko, Jennifer and Rees, Judy R and Yan, Shaofeng and Nagore, Eduardo and Bosenberg, Marcus and Rothberg, Bonnie Gould and Osman, Iman and Lee, Jeffrey E and Saenger, Yvonne and Bogner, Paul and Thompson, Cheryl L and Gerstenblith, Meg and Holmen, Sheri L and Funchain, Pauline and Brunsgaard, Elise and Depcik-Smith, Natalie D and Luo, Li and Boyce, Tawny and Orlow, Irene and Begg, Colin B and Berwick, Marianne and Thomas, Nancy E and InterMEL Study Group, InterMEL Study Group},
  title = {DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance},
  journal = {JCO Precision Oncology},
  year = {2024},
  number = {8},
  doi = {10.1200/po-24-00375}
}
Kostenlos starten →